News
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success -
-
-
-
-
-
PRESS RELEASE
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
Zomedica strengthens European presence and product portfolio through expanded distribution agreement with Grovet b.v., enhancing market position in veterinary diagnostics and therapeutic device sectors -
-